QUALITY OF BIOTECHNOLOGICAL PRODUCTS:

b. Evidence of an FDA establishment number for the manufacturing site and inclusion of the particular product on the manufacturer’s drug listing with the FDA; or. c. For an active pharmaceutical ingredient, evidence that the manufacturer’s bulk drug substance is identified as an ingredient in an FDA approved finished product; or. d. ................
................